U.S. Aid Reductions Disrupt Crucial HIV Initiatives in South Africa
The Impact of U.S. Aid Cut on HIV Research in South Africa
Just as the anticipation was mounting for a groundbreaking clinical trial of an HIV vaccine in South Africa, an unexpected email threw everything into disarray. The message was clear: "Stop all work."
This shockwave came courtesy of the Trump administration's decision to withdraw U.S. funding, dismantling key foreign aid initiatives. The repercussions were felt deeply by the researchers involved, especially those working on the BRILLIANT project, an endeavor…